Osteosarcoma Relapse After Combined Modality Therapy: An Analysis of Unselected Patients in the Cooperative Osteosarcoma Study Group (COSS)Beate Kempf‐Bielack, Kurt Winkler, U. Göbel et al.|Journal of Clinical Oncology|2005Cited by 654
Cost and Clinical Analysis of Autologous Hematopoietic Stem Cell Mobilization with G-CSF and Plerixafor Compared to G-CSF and CyclophosphamidePaul Shaughnessy, Peter A. McSweeney, Miguel Islas‐Ohlmayer et al.|Transplantation and Cellular Therapy|2010Cited by 88
Plerixafor Plus G-CSF Compared to Chemotherapy Plus G-CSF for Mobilization of Autologous CD34+ Cells Resulted in Similar Cost but More Predictable Days of Apheresis and Less Hospitalization.Paul Shaughnessy, Peter A. McSweeney, Miguel Islas‐Ohlmayer et al.|Blood|2009Cited by 8